NGM stock forecast
Our latest prediction for NGM Biopharmaceuticals, Inc.'s stock price was made on the March 25, 2020 when the stock price was at 13.33$.
In the short term (2weeks), NGM's stock price should outperform the market by 1.01%. During that period the price should oscillate between -9.64% and +13.70%.
In the medium term (3months), NGM's stock price should outperform the market by 3.48%. During that period the price should oscillate between -24.02% and +33.52%.Get email alerts
About NGM Biopharmaceuticals, Inc.
NGM Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for cardio-metabolic, liver, oncologic, and ophthalmic diseases. Its portfolio include aldafermin (NGM282), NGM313, NGM120, NGM217, NGM621, and NGM395. The company was founded by Jin-Long Chen in 2008 and is headquartered in South San Francisco, CA.
At the moment the company generates 104M USD in revenues.
On its last earning announcement, the company reported a loss of -0.85$ per share.
The book value per share is 2.88$
Three months stock forecastMarch 25, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|